Gland Pharma on Tuesday said its profit after tax declined by 26 per cent to Rs 144 crore for the first quarter ended June 30, 2024. The Hyderabad-based drug maker has reported a profit after tax (PAT) of Rs 194 crore in the April-June quarter of last fiscal.
